Mats Eriksson

Uppsala University

H指数:29

被引数:3,182

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Beyond Pain Scores: The Emerging Era of Pain Biomarkers

超越疼痛评分：疼痛生物标志物的崭新时代

Biomedicines

IF3.9

2026-10-030

Long-Term Monitoring of Everolimus Concentrations in Routine Clinical Practice: Evaluation of Patient Percentiles as Quality Indicator and Impact of Analytical Method Change

依维莫司浓度在常规临床实践中的长期监测：评估患者百分位数作为质量指标及分析方法变更的影响

Pharmaceuticals

IF4.8

2026-09-080

Creatinine, but not cystatin C, varies diurnally in critically ill children: a retrospective analysis from a tertiary pediatric intensive care unit

肌酐而非胱抑素C在危重儿童中呈日间变化：一项来自三级儿科重症监护室的回顾性分析

European Journal of Pediatrics

IF2.6

2026-04-240

OAAI

Significant correlations between blood lipids, cytokines, and C-reactive protein in healthy humans

健康人群中血脂、细胞因子和C反应蛋白之间存在显著相关性。

Lipids in Health and Disease

IF4.2

2026-04-090

OAAI

Decreasing Tacrolimus Concentrations in Routine Therapeutic Drug Monitoring Data Indicate Adherence to Updated Therapeutic Goals

在常规治疗药物监测数据中，他克莫司浓度的下降表明患者遵循了更新的治疗目标。

Biomedicines

IF3.9

2026-01-030

OAAI

Mapping Interactions Between Cytokines, Chemokines, Growth Factors, and Conventional Biomarkers in COVID-19 ICU-Patients

绘制COVID-19重症监护病房患者中细胞因子、趋化因子、生长因子与传统生物标志物之间的相互作用图谱

International Journal of Molecular Sciences 2025, Vol. 26, Page 11419

IF4.9

2025-11-260

OAAI

Methodological comparison between salivary and plasma inflammatory biomarkers in third molar surgery patients

唾液与血浆炎症生物标志物在第三磨牙手术患者中的方法学比较

BMC Oral Health

IF3.1

2025-11-230

On the rapid determination of strontium-90 in milk and drinking water using ICP-MS/MS for emergency preparedness

JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY

IF1.6

2025-10-010

OAAI

Significant Associations Between Blood Cell Counts and Plasma Cytokines, Chemokines, and Growth Factors

血细胞计数与血浆细胞因子、趋化因子和生长因子之间的显著关联

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

IF4.9

2025-04-250

Avian Antibodies as Potential Therapeutic Tools

ANTIBODIES

IF2.7

2025-02-140

OAAI

Transition of patients with familial chylomicronaemia syndrome from volanesorsen to olezarsen: safety and pharmacokinetic results

EUROPEAN HEART JOURNAL

IF35.6

2024-10-280

PRE

Role of NO in Disease: Good, Bad or Ugly

BIOMEDICINES

IF3.9

2024-06-180

OAAI

Validation of Serum Calprotectin Relative to Other Biomarkers of Infection in Febrile Infants Presenting to the Emergency Department

在急诊科就诊的发热婴儿中，血清钙卫蛋白相对于其他感染生物标志物的验证

ANTIBIOTICS-BASEL

IF4.6

2024-05-070

Biomarkers in Pain

BIOMEDICINES

IF3.9

2023-09-181

OAAI

Analysis of Calprotectin as an Early Marker of Infections Is Economically Advantageous in Intensive Care-Treated Patients

BIOMEDICINES

IF3.9

2023-08-014

OAAI

Differential Bias for Creatinine- and Cystatin C-Derived Estimated Glomerular Filtration Rate in Critical COVID-19

临界新型冠状病毒肺炎中肌酐和胱抑素C衍生的估计肾小球滤过率的差异偏倚

BIOMEDICINES

IF3.9

2022-10-264

OAAI

Chicken antibodies are highly suitable for particle enhanced turbidimetric assays

FRONTIERS IN IMMUNOLOGY

IF5.9

2022-10-114

OAAI

Plasma Leptin Is Increased in Intensive Care Patients with COVID-19-An Investigation Performed in the PronMed-Cohort

在PronMed队列中进行COVID-19-An调查的重症监护患者中血浆瘦素增加

BIOMEDICINES

IF3.9

2021-12-2120

OAAI

A Comparison between Endostatin and Conventional Biomarkers on 30-Day Mortality and Renal Replacement Therapy in Unselected Intensive Care Patients

BIOMEDICINES

IF3.9

2021-11-030

OAAI

The effect of hemorrhagic shock and intraosseous adrenaline injection on the delivery of a subsequently administered drug - an experimental study

SCANDINAVIAN JOURNAL OF TRAUMA RESUSCITATION & EMERGENCY MEDICINE

IF3.1

2019-03-082

OAAI

Mats Eriksson

个人简介

教育背景

工作经历

荣誉奖项

研究方向